Eco R1 Capital, LLC Centessa Pharmaceuticals PLC Transaction History
Eco R1 Capital, LLC
- $3.51 Billion
- Q1 2024
A detailed history of Eco R1 Capital, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Eco R1 Capital, LLC holds 5,618,779 shares of CNTA stock, worth $50.7 Million. This represents 1.81% of its overall portfolio holdings.
Number of Shares
5,618,779
Previous 5,618,779
-0.0%
Holding current value
$50.7 Million
Previous $44.7 Million
41.96%
% of portfolio
1.81%
Previous 1.29%
Shares
7 transactions
Others Institutions Holding CNTA
# of Institutions
73Shares Held
84.5MCall Options Held
17.7KPut Options Held
5K-
Medicxi Ventures Management (Jersey) LTD20MShares$180 Million59.15% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$90 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$87.4 Million2.56% of portfolio
-
Vida Ventures Advisors, LLC3.93MShares$35.5 Million65.7% of portfolio
-
Perceptive Advisors LLC New York, NY3.08MShares$27.8 Million0.73% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $852M
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...